HOLX - Hologic's recall of BioZorb Markers classified as FDA's most serious type
2024-05-22 14:42:59 ET
More on Hologic
- Hologic: Women's Health Play Looks Healthier Itself
- Hologic, Inc. (HOLX) Q2 2024 Earnings Call Transcript
- Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M
- Hologic Q2 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Hologic